Non-immunoglobulin E-mediated gastrointestinal food allergies in children with Down syndrome: An epidemiological study
Background: Non-immunoglobulin E-mediated gastrointestinal food allergies (non-IgE-GI-FAs) in children with Down syndrome (DS) tend to be more severe, with some children presenting with sepsis-like symptoms. However, the epidemiology of this condition remains unknown. This study aimed to investigate...
Saved in:
| Main Authors: | Fumiko Okazaki, MD, Hiroyuki Wakiguchi, MD, PhD, Yuno Korenaga, MD, Mototsugu Shimokawa, PhD, Tsuyoshi Tanabe, MD, PhD, Ken Fukuda, MD, PhD, Masanari Hasegawa, MD, PhD, Miho Shimizu, MD, PhD, Reiji Hirano, MD, PhD, Tadashi Moriwake, MD, PhD, Mai Kawamura, MD, Hiroshi Tateishi, MD, PhD, Ryo Kadoya, MD, PhD, Yasumasa Tsuda, MD, Takaomi Sekino, MD, PhD, Norimichi Tashiro, MD, PhD, Hirofumi Inoue, MD, PhD, Yoshiko Nawata, MD, Makoto Mizutani, MD, PhD, Takashi Maki, MD, Kenji Nakatsuka, MD, PhD, Shunji Hasegawa, MD, PhD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | World Allergy Organization Journal |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455125000808 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L
by: Hideyuki Harada, MD, PhD, et al.
Published: (2025-06-01) -
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies
by: Yusuke Inoue, MD, PhD, et al.
Published: (2025-08-01) -
Efficacy of Combined Use of PELNAC and Platelet-rich Plasma in Promoting Wound Healing
by: Hiroshi Fujimaki, MD, PhD, et al.
Published: (2025-08-01) -
Independent association of a 17q21 variant with exacerbations in type 2–low adult asthma
by: Yumi Ishiyama, MD, et al.
Published: (2025-08-01) -
A Phase I/II Study of Ultra-Hypofractionated Carbon-ion Radiation therapy for Low- and Intermediate-Risk Localized Prostate Cancer
by: Noriyuki Okonogi, MD, PhD, et al.
Published: (2025-03-01)